Fluorescite (fluorescein injection)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   February 2016 CONTRAINDICATIONS Hypersensitivity FLUORESCITE® Injection 10% is contraindicated in patients with known...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts